Back to news

Expedia Group Slides as Investors Weigh Lawsuit, Prior Target Cuts, and Approaching Earnings

Investivoq PriceTracker

Expedia Group (EXPE) is down 3.3% today. Here is some analysis on what might have caused this price movement.

Analysis: The most likely driver appears to be a mix of caution rather than one fresh headline. Investors are still digesting an antitrust lawsuit filed earlier this month, recent analyst price-target reductions tied to softer travel trends, and positioning ahead of Expedia Group’s scheduled November 4, 2026 earnings release.

Details:

  • Expedia Group recently announced that it will webcast third-quarter 2026 results on November 4, which can lead to cautious trading as investors wait for updated booking and demand commentary.
  • A Wells Fargo note earlier in October lowered its price target on the shares and pointed to choppy travel trends, a low point in quarterly nights growth, and the prospect of slowing bookings growth.
  • A proposed antitrust class action was filed on October 2, 2026, alleging Expedia used hotel pricing practices that kept room rates artificially high, adding a legal overhang to the stock.
  • Because no major company press release appears tied directly to today’s decline, this could also be normal volatility in a stock that has already seen shifting sentiment around online travel demand and valuation.

    • Sources:

    Expedia Group Investor Relations, TipRanks, Berger Montague

    Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

    $EXPE Insider Trading Activity

    EXPE Insider Trades

    $EXPE insiders have traded $EXPE stock on the open market 6 times in the past 6 months. Of those trades, 0 have been purchases and 6 have been sales.

    Here’s a breakdown of recent trading of $EXPE stock by insiders over the last 6 months:

    • ROBERT J DZIELAK (Chief Legal Officer & Sec'y) has made 0 purchases and 4 sales selling 10,709 shares for an estimated $3,038,851.
    • LANCE A SOLIDAY (SVP & Chief Accounting Officer) has made 0 purchases and 2 sales selling 3,750 shares for an estimated $1,118,003.

    To track insider transactions, check out Investivoq's insider trading dashboard. You can access data on insider stock transactions through the Investivoq API insider transaction endpoint.

    EARLY ACCESS
    Receive EXPE Data Alerts
    Real-time alerts on filings, insider trades, and market signals — before everyone else.
    Get Alerts →

    $EXPE Hedge Fund Activity

    We have seen 591 institutional investors add shares of $EXPE stock to their portfolio, and 474 decrease their positions in their most recent quarter.

    Here are some of the largest recent moves:

    • JPMORGAN CHASE & CO added 2,417,016 shares (+inf%) to their portfolio in Q2 2026, for an estimated $618,466,054
    • PACER ADVISORS, INC. added 1,414,534 shares (+inf%) to their portfolio in Q2 2026, for an estimated $361,950,959
    • SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 746,684 shares (+inf%) to their portfolio in Q2 2026, for an estimated $191,061,501
    • ALKEON CAPITAL MANAGEMENT LLC removed 650,000 shares (-26.3%) from their portfolio in Q2 2026, for an estimated $166,322,000
    • FIRST TRUST ADVISORS LP added 637,669 shares (+53.5%) to their portfolio in Q2 2026, for an estimated $163,166,743
    • BRIDGEWATER ASSOCIATES, LP removed 591,187 shares (-94.9%) from their portfolio in Q2 2026, for an estimated $151,272,929
    • BARCLAYS PLC added 562,948 shares (+90.9%) to their portfolio in Q2 2026, for an estimated $144,047,134

    To track hedge funds' stock portfolios, check out Investivoq's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Investivoq API 13F endpoint.

    $EXPE Analyst Ratings

    Wall Street analysts have issued reports on $EXPE in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

    Here are some recent analyst ratings:

    • BTIG issued a "Buy" rating on 05/08/2026

    To track analyst ratings and price targets for $EXPE, check out Investivoq's $EXPE forecast page.

    $EXPE Price Targets

    Multiple analysts have issued price targets for $EXPE recently. We have seen 8 analysts offer price targets for $EXPE in the last 6 months, with a median target of $263.0.

    Here are some recent targets:

    • John Staszak from Argus Research set a target price of $315.0 on 07/07/2026
    • Ken Gawrelski from Wells Fargo set a target price of $303.0 on 06/30/2026
    • Jake Fuller from BTIG set a target price of $330.0 on 06/09/2026
    • Tom White from DA Davidson set a target price of $250.0 on 05/18/2026
    • Shyam Patil from Susquehanna set a target price of $250.0 on 05/11/2026
    • Trevor Young from Barclays set a target price of $264.0 on 05/11/2026
    • Thomas Champion from Piper Sandler set a target price of $245.0 on 05/08/2026

    This article is not financial advice. See Investivoq's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.